PCI 2023: CONTROVERSIES AND HOT TOPICS IN INTERVENTIONAL CARDIOLOGY

Monday, February 27, 2023

4:30 PM – 5:33 PM ET

Moderator(s)

Rasha Al-Lamee, MA, MD, PhD

Interventional Cardiology Consultant
Imperial College London
London, England, United Kingdom

Disclosure(s): Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)
Gregg W. Stone, MD, FACC, MSCAI (he/him/his)

Physician
Mount Sinai
New York, New York, United States

Disclosure(s): Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)

Disclosure(s):

Rasha Al-Lamee, MA, MD, PhD: Abbott Structural, Anteris, AriaCV, Boston Scientific, Edwards Lifesciences, Medtronic, VDyne, WL Gore, Xylocor.: Honoraria (Ongoing), Honoraria (Ongoing); Jannsen: Advisory Committee/Board Member (Ongoing); Menarini Pharmaceuticals: Honoraria (Ongoing); Philips, Abbott; GE Healthcare; Asahi Intecc; Teleflex; Abiomed; Cardiovascular Systems, Inc.: Honoraria (Ongoing)

Gregg W. Stone, MD, FACC, MSCAI: Abbott, Abiomed, Bioventrix, Cardiovascular Systems Inc, Phillips, Biosense-Webster, Shockwave, Vascular Dynamics, Pulnovo and V-wave: University Grants/Research Support (Ongoing); Abiomed, CorFlow, Apollo Therapeutics, Cardiomech, Gore, Amgen, Millennia Biopharma: Consultant (Terminated); Ancora, Cagent, Applied Therapeutics, Biostar family of funds, SpectraWave, Orchestra Biomed, Aria, Cardiac Success, Valfix, Xenter: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Medtronic, Pulnovo, Infraredx: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Valfix, TherOx, Robocath, HeartFlow, Ablative Solutions, Miracor, Neovasc, Ancora, Vectorious, Elucid Bio, Occlutech, Impulse Dynamics, Adona Medical: Consultant (Ongoing)